GLOFITAMAB-GXBM for Diffuse large b-cell lymphoma recurrent: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

There are 10 adverse event reports in the FDA FAERS database where GLOFITAMAB-GXBM was used for Diffuse large b-cell lymphoma recurrent.

Most Reported Side Effects for GLOFITAMAB-GXBM

Side Effect	Reports	%	Deaths	Hosp.
Cytokine release syndrome	107	21.5%	16	41
Disease progression	68	13.7%	40	13
Off label use	68	13.7%	9	17
Death	67	13.5%	67	6
Pyrexia	45	9.0%	12	8
No adverse event	28	5.6%	0	0
Immune effector cell-associated neurotoxicity syndrome	25	5.0%	13	18
Infection	20	4.0%	11	13
Pneumonia	14	2.8%	9	3
Condition aggravated	12	2.4%	11	0
Covid-19	10	2.0%	4	3
Drug ineffective	10	2.0%	4	2
Sepsis	10	2.0%	5	5
Diffuse large b-cell lymphoma recurrent	9	1.8%	0	1
Dyspnoea	9	1.8%	2	5